News & Updates

If You Are Ever Late Filing for Your CE, This New ACPE Policy Will Affect You

Jan 8, 2018 Tags: NCPA

Starting in 2018, there will be a charge of $200 from ACPE for filing for CE after the 60-day submission deadline. NCPA has established "free pass" filing periods for March, August, and December of 2018 where your overdue activities can still be filed at no charge. Please contact Sue Hagler at with any questions and activities you need submitted. Have the following information ready: e-Profile ID, DOB (MMDD), and ACPE UAN for each activity.

Read more

Specialty Pharmacy is a Lucrative Opportunity for Community Pharmacy

Jan 19, 2016 Tags: Business, NCPA, Specialty Pharmacy

he traditional pharmacy business model is under siege as it faces challenges from healthcare reform and competition. As community pharmacies scramble to survive, the specialty pharmacy model offers a lucrative opportunity for growth.

The key to success? You’ll need to understand and prepare for a wide variety of challenges on fronts ranging from accreditation to marketing. That’s the message from community pharmacists who are urging their colleagues to take advantage of the growth in specialty pharmacy.

Read more

Web Search Engine to Warn About Fake Online Pharmacies

Sep 24, 2015 Tags:

To help consumers avoid potentially unsafe online drug outlets, Bing will provide a new warning message on certain search results in “This warning will appear if a Bing user clicks on a pharmaceutical site that has been cited by the FDA as a fake online pharmacy engaged in illegal activity, such as offering dangerous, unapproved and misbranded prescription drugs to US consumers,” indicates Bing in a blog post. The warning message informs consumers that Food and Drug Administration (FDA) has issued a Warning Letter to the site about potentially unsafe drugs and presents consumers with a link to more information about choosing a safe online pharmacy. An example of the warning message is available in the Bing blogs post.

Since 2008, NABP has been collecting data on websites selling medicine illegally online to US patients. NABP has reviewed over 11,000 Internet drug outlets, finding that 96.13% of the sites reviewed operate out of compliance with US pharmacy laws and practice standards, and identifying these sites as “Not Recommended.” The Association launched the .Pharmacy Top-Level Domain (TLD) Program to provide consumers around the world a means to identify safe and legal online pharmacies and related resources. NABP will grant use of the .pharmacy domain only to legitimate website operators that adhere to pharmacy laws in the jurisdictions in which they are based and in which their patients and customers reside, so that consumers can easily find safe online pharmacies. More information about the .Pharmacy TLD Program, including a list of approved entities with registered .pharmacy domain names, is available online.

Read more

Most College Students Misusing Prescription Drugs Begin Non-medical Use in Winter Months

Sep 4, 2015 Tags: Child Health, Pharmaceuticals

Winter is the peak season for full-time college students to start non-medical use of prescription drugs, such as pain relievers and stimulants, indicates a new study by SAMHSA. The study, which tracks initiation by month, reveals that in the past year, approximately 251,000 full-time college students started the non-medical use of pain relievers, with an average of 700 initiates a day. However, this rate rises to 850 initiates a day during December, according the study. Further, more students start non-medical use of stimulant medications in November, December, and April. Specifically, about 500 students per day start abusing stimulants during those months, compared with 400 students on an average day. SAMHSA notes that because the rise in the initiation of non-medical use of prescription stimulants coincides with the times of the year that many college final exams and midterm exams occur, this may suggest that students believe non-medical use of stimulants can benefit academic performance.

Read more